Nintedanib and Pirfenidone New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions

作者:Raghu Ganesh*; Selman Moises
来源:American Journal of Respiratory and Critical Care Medicine, 2015, 191(3): 252-254.
DOI:10.1164/rccm.201411-2044ed